ConductScience.org, home

Paper39476339

Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.

Bliddal H and 12 others. N Engl J Med, 2024. Cited by 322 papers, by iCite.

Cite this record

ConductScience Library. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. Papers, record 39476339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39476339

Download JSON
Disease
obesity disorder354 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.
PubMed
Journal
N Engl J Med
PubMed
Year
2024
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Multicenter Study, Clinical Trial, Phase III
PubMed
Citations, by iCite
322
iCite
Relative citation ratio, by iCite
61.53, provisional
iCite
Revised in PubMed
2026-05-18
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bliddal HHenning
2Bays HHarold
3Czernichow SSébastienhttps://orcid.org/0000-0001-7353-2532
4Uddén Hemmingsson JJoanna
5Hjelmesæth JJøran
6Hoffmann Morville TThomas
7Koroleva AAnna
8Skov Neergaard JJesper
9Vélez Sánchez PPatricia
10Wharton SSean
11Wizert AAlicja
12Kristensen LELars E
13STEP 9 Study GroupGroup

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ObesityMajor topic
Osteoarthritis, KneeMajor topic
Weight LossMajor topic
Glucagon-Like Peptide-1 Receptor AgonistsMajor topic
ArthralgiaMajor topic
Aged
Female
Humans
Male
Middle Aged
Body Mass Index
Combined Modality Therapy
Double-Blind Method
Drug Administration Schedule
Injections, Subcutaneous
Counseling
Caloric Restriction
Pain Measurement
Semaglutide

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Novo NordiskPubMed

Source PubMed

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT05064735Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee OsteoarthritisResultsYesClinicalTrials.gov
NCT07731256Semaglutide for Low Back PainBackgroundClinicalTrials.gov

Download CSV of trials

Cited by236

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 322 citations.

PMIDTitleJournalYearIn PapersSource
42978648Availability of age-stratified evidence for GLP1 receptor agonists and SGLT2 inhibitors: an analysis of European public assessment reports with a focus on older patients.Front Pharmacol2026https://conductscience.org/library/papers/42978648PubMed
42942810Retatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging Phase 3 Evidence.Pharmaceutics2026https://conductscience.org/library/papers/42942810PubMed
42942239Plant-Derived Polyphenols in Osteoarthritis: Mechanisms, Delivery Systems, and Therapeutic Synergy.Life (Basel)2026https://conductscience.org/library/papers/42942239PubMed
42941937Exploring Pathophysiological Processes Shared Between Type 2 Diabetes Mellitus and Osteoarthritis.Int J Mol Sci2026https://conductscience.org/library/papers/42941937PubMed
42905201Dual GIP/GLP-1 receptor agonist versus selective GLP-1 receptor agonist in patients undergoing primary total knee or hip arthroplasty.Eur J Orthop Surg Traumatol2026https://conductscience.org/library/papers/42905201PubMed
42903858The emerging role of subchondral bone homeostasis in osteoarthritis.J Orthop Translat2026https://conductscience.org/library/papers/42903858PubMed
42893003Better osteoarthritis care requires prevention and stratification.Mil Med Res2026https://conductscience.org/library/papers/42893003PubMed
42892878Physical Activity Patterns in Adults Taking Glucagon-Like Peptide 1 Receptor Agonists: An All of Us Cross-sectional Study.Diabetes Obes Cardiometab CARE2026https://conductscience.org/library/papers/42892878PubMed
42889937Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity.Diabetes Obes Cardiometab CARE2026https://conductscience.org/library/papers/42889937PubMed
42884570GLP-1 Receptor Agonists, Gut Microbiota, and Chronic Pain: Nutritional Signaling at the Gut-Brain Axis.Nutrients2026https://conductscience.org/library/papers/42884570PubMed
4288116915-PGDH inhibition in osteoarthritis: PGE2 skeletal interoception, cartilage regeneration and compartment-managed disease modification.Bone Res2026https://conductscience.org/library/papers/42881169PubMed
42875481Emerging therapies for knee osteoarthritis.Nat Rev Rheumatol2026https://conductscience.org/library/papers/42875481PubMed
42860897Glucagon-Like Peptide-1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review.Ann Clin Transl Neurol2026https://conductscience.org/library/papers/42860897PubMed
42851913Artificial intelligence in the biomechanics of knee osteoarthritis: biomechanical phenotyping, risk stratification, diagnosis, treatment and clinical translation-a narrative review.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42851913PubMed
42841007Non-surgical management of knee osteoarthritis: a stepped conservative care paradigm for early-stage disease and high-risk populations.Front Surg2026https://conductscience.org/library/papers/42841007PubMed
42825923Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Diabetologia2026https://conductscience.org/library/papers/42825923PubMed
42778434What does the gut microbiome teach us about osteoarthritis development and progression?Best Pract Res Clin Rheumatol2026https://conductscience.org/library/papers/42778434PubMed
42774139The incretin-joint axis: weight-independent mechanisms and disease-modifying potential in chronic arthropathies.Rheumatol Adv Pract2026https://conductscience.org/library/papers/42774139PubMed
42772870Systematic review of cost-effectiveness analyses of weight loss interventions for knee osteoarthritis.BMJ Open2026https://conductscience.org/library/papers/42772870PubMed
42772706Impact of an early body mass index maintenance intervention at ART initiation on diabetes risk: Insights from a computer simulation study.Ann Epidemiol2026https://conductscience.org/library/papers/42772706PubMed

See all 236 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740

Source NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
SEMAGLUTIDECHEMBL2108724Results1https://conductscience.org/library/drugs/CHEMBL2108724

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39476339

GET https://conductscience.org/api/papers/v1/39476339/cited_by?page=2